Back to Search
Start Over
Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol:A Prospective Analysis of the IMPACT Trial
- Source :
- Han , M K , Criner , G J , Dransfield , M T , Halpin , D M G , Jones , C E , Kilbride , S , Lange , P , Lipson , D A , Lomas , D A , Martinez , F J , Naya , I , Pascoe , S J , Wise , R A & Singh , D 2019 , ' Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol : A Prospective Analysis of the IMPACT Trial ' , American Journal of Respiratory and Critical Care Medicine , vol. 199 , no. A2438 , A102 .
- Publication Year :
- 2019
Details
- Database :
- OAIster
- Journal :
- Han , M K , Criner , G J , Dransfield , M T , Halpin , D M G , Jones , C E , Kilbride , S , Lange , P , Lipson , D A , Lomas , D A , Martinez , F J , Naya , I , Pascoe , S J , Wise , R A & Singh , D 2019 , ' Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol : A Prospective Analysis of the IMPACT Trial ' , American Journal of Respiratory and Critical Care Medicine , vol. 199 , no. A2438 , A102 .
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1322726530
- Document Type :
- Electronic Resource